Clinical trial
Study Evaluating MOA-728 Administered in Healthy Men
NCT00427258 · Bausch Health Americas, Inc., Industry · Withdrawn
Key facts
| NCT number | NCT00427258 |
|---|---|
| Title | Study Evaluating MOA-728 Administered in Healthy Men |
| Official title | An Open-Label, Single-Dose Study of the Mass Balance and Metabolic Disposition of Orally Administered [14C]MOA-728 in Healthy Men |
| Lead sponsor | Bausch Health Americas, Inc., Industry |
| Status | Withdrawn |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Healthy |
| Intervention type | Drug |
| Interventions | MOA-728 |
| Enrollment | 0 |
| Start date | Jan 1, 2010 |
| First posted | Jan 29, 2007 |
| Last update posted | Nov 29, 2019 |
At a glance
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: